Top

Published in:

Open Access 01-12-2024 | Sitagliptin | Correction

Correction: Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis

Authors: Xiao-Yong Huang, Peng-Fei Zhang, Chuan-Yuan Wei, Rui Peng, Jia-Cheng Lu, Chao Gao, Jia-Bing Cai, Xuan Yang, Jia Fan, Ai-Wu Ke, Jian Zhou, Guo-Ming Shi

Published in: Molecular Cancer | Issue 1/2024

Excerpt

Correction: Mol Cancer 19, 92 (2020) …

Huang XY, Zhang PF, Wei CY, et al. Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis. Mol Cancer. 2020;19:92. https://doi.org/10.1186/s12943-020-01213-6.CrossRefPubMedPubMedCentral

Title: Correction: Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis
Authors: Xiao-Yong Huang
Peng-Fei Zhang
Chuan-Yuan Wei
Rui Peng
Jia-Cheng Lu
Chao Gao
Jia-Bing Cai
Xuan Yang
Jia Fan
Ai-Wu Ke
Jian Zhou
Guo-Ming Shi
Publication date: 01-12-2024
Publisher: BioMed Central
Keyword: Sitagliptin
Published in: Molecular Cancer / Issue 1/2024
Electronic ISSN: 1476-4598
DOI: https://doi.org/10.1186/s12943-024-01969-1

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2024

Evolution of cell therapy for renal cell carcinoma

Organoids derived from patients provide a new opportunity for research and individualized treatment of malignant peritoneal mesothelioma

tRNA-derived small RNAs in human cancers: roles, mechanisms, and clinical application

Multifaceted roles for BCL3 in cancer: a proto-oncogene comes of age

Small cells – big issues: biological implications and preclinical advancements in small cell lung cancer

rs822336 binding to C/EBPβ and NFIC modulates induction of PD-L1 expression and predicts anti-PD-1/PD-L1 therapy in advanced NSCLC

Keynote webinar | Spotlight on antibody–drug conjugates in cancer